MedTrace Logo

Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

NCT01843361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2013-04-30

No results posted yet for this study

Summary

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Conditions

Sponsors & Collaborators

  • Ruhr University of Bochum

    lead OTHER

Principal Investigators

  • Saskia H Meves, MD · Ruhr University Bochum, Department of Neurology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01843361 on ClinicalTrials.gov